Abstract:This study investigated the effects of microRNA-135a (miR-135a) targeting of glycogen synthase kinase 3β (GSK3β) on the epithelial–mesenchymal transition (EMT), migration and invasion of bladder cancer (BC) cells by mediating the Wnt/β-catenin signaling pathway. BC and adjacent normal tissues were collected from 165 BC patients. Western blotting and quantitative real-time PCR were used to detect the expression of GSK3β, β-catenin, cyclinD1, E-cadherin, vimentin and miR-135a in BC tissues and cells. Cells were assigned to blank, negative control (NC), miR-135a mimics, miR-135a inhibitors, small interfering RNA (siRNA)-GSK3β or miR-135a inhibitors+siRNA-GSK3β groups. miR-135a, β-catenin, cyclinD1 and vimentin expression increased, while GSK3β and E-cadherin expression decreased in BC tissues compared with adjacent normal tissues. Compared with the blank and NC groups, the expression of miR-135a, β-catenin, cyclinD1 and vimentin was higher, and cell proliferation, migration, invasion and tumor growth were increased in the miR-135a mimics and siRNA-GSK3β groups. These groups showed an opposite trend in GSK3β and E-cadherin expression and cell apoptosis. The miR-135a inhibitors group was inversely correlated with the blank and NC groups. It was concluded that miR-135a accelerates the EMT, invasion and migration of BC cells by activating the Wnt/β-catenin signaling pathway through the downregulation of GSK3β expression. The small regulatory RNA molecule microRNA-135a contributes to bladder cancer by stimulating cell proliferation and migration. Dr Nan Zhang and colleagues at Zhejiang University Medical College in Hangzhou, China, examined both bladder cancer and adjacent normal tissues in 156 patients. The levels of microRNA-135a and of the signaling protein β-catenin were higher in the cancerous tissue. In contrast, the levels of the tumor suppressor glycogen synthase kinase-3 beta (GSK-3β) were lower, suggesting that micro-RNA135a triggers signaling through the Wnt/β-catenin pathway. This evolutionarily conserved pathway is crucial for orchestrating development and when deregulated can lead to diseases including cancer and osteoporosis. Increased expression of micro-RNA135a stimulated cell proliferation and motility in human bladder cells and tumor growth in mice through this signaling pathway. These findings could lead to new treatment strategies for bladder cancer patients.

MicroRNA-335 Inhibits Bladder Cancer Cell Growth and Migration by Targeting Mitogen-Activated Protein Kinase 1

MiRNA‐516a Promotes Bladder Cancer Metastasis by Inhibiting MMP9 Protein Degradation Via the AKT/FOXO3A/SMURF1 Axis

MicroRNA-335 is Downregulated in Bladder Cancer and Inhibits Cell Growth, Migration and Invasion Via Targeting ROCK1.

MiR-362-5p, Which is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI

Mir-451 Inhibits Invasion and Proliferation of Bladder Cancer by Regulating EMT.

Mir-135a Enhances Cellular Proliferation Through Post-Transcriptionally Regulating PHLPP2 and FOXO1 in Human Bladder Cancer

MicroRNA-34a Inhibits Bladder Cancer Cell Migration and Invasion, and Upregulates PTEN Expression

Effects of Microrna-135A on the Epithelial–mesenchymal Transition, Migration and Invasion of Bladder Cancer Cells by Targeting GSK3β Through the Wnt/β-catenin Signaling Pathway

MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met

CCND1, NOP14 and DNMT3B Are Involved in Mir‐502‐5p–mediated Inhibition of Cell Migration and Proliferation in Bladder Cancer

MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.

MicroRNA-124-3p Inhibits Cell Migration and Invasion in Bladder Cancer Cells by Targeting ROCK1

MicroRNA-335 Targets the MEK/ERK Pathway to Regulate the Proliferation and Metastasis of Colon Cancer

Mir-1307-5p Suppresses Proliferation and Tumorigenesis of Bladder Cancer Via Targeting MDM4 and the Hippo Signaling Pathway

Mir-335 Inhibits the Proliferation and Invasion of Clear Cell Renal Cell Carcinoma Cells Through Direct Suppression of BCL-W

Downregulation of Microrna-532-5p Promotes the Proliferation and Invasion of Bladder Cancer Cells Through Promotion of HMGB3/Wnt/β-catenin Signaling

Microrna-195 Inhibits Cell Proliferation in Bladder Cancer Via Inhibition of Cell Division Control Protein 42 Homolog/signal Transducer and Activator of Transcription-3 Signaling

MicroRNA-335 Inhibits the Growth, Chemo-Sensitivity, and Metastasis of Human Breast Cancer Cells by Targeting MAP3K2.

Microrna-155 Promotes Bladder Cancer Growth By Repressing The Tumor Suppressor Dmtf1

Tumor-suppressing Effects of Microrna-612 in Bladder Cancer Cells by Targeting Malic Enzyme 1 Expression.

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1